Biomerica (BMRA) Shares Outstanding (Weighted Average) (2016 - 2026)
Biomerica's Shares Outstanding (Weighted Average) history spans 17 years, with the latest figure at $3.0 million for Q1 2026.
- On a quarterly basis, Shares Outstanding (Weighted Average) rose 25.52% to $3.0 million in Q1 2026 year-over-year; TTM through Feb 2026 was $3.0 million, a 25.52% increase, with the full-year FY2025 number at $2.3 million, up 9.22% from a year prior.
- Shares Outstanding (Weighted Average) hit $3.0 million in Q1 2026 for Biomerica, up from $2.8 million in the prior quarter.
- Over the last five years, Shares Outstanding (Weighted Average) for BMRA hit a ceiling of $16.8 million in Q3 2023 and a floor of $2.1 million in Q2 2024.
- Historically, Shares Outstanding (Weighted Average) has averaged $8.8 million across 5 years, with a median of $12.6 million in 2022.
- Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 87.5% in 2024 and later surged 30.77% in 2025.
- Tracing BMRA's Shares Outstanding (Weighted Average) over 5 years: stood at $13.3 million in 2022, then rose by 26.75% to $16.8 million in 2023, then tumbled by 87.39% to $2.1 million in 2024, then skyrocketed by 30.77% to $2.8 million in 2025, then increased by 8.51% to $3.0 million in 2026.
- Business Quant data shows Shares Outstanding (Weighted Average) for BMRA at $3.0 million in Q1 2026, $2.8 million in Q4 2025, and $2.6 million in Q3 2025.